Stem Cell Therapy Treatment for Autism by Dr Alok Sharma, Mumbai, India. Part 2 Improvement seen in just 7 months after Stem Cell Therapy Treatment for Autism by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Emotional respons... By: Neurogen Brain and Spine Institute … Continue reading →

FRIDAY, July 12 (HealthDay News) -- People with epilepsy appear to show signs of mild memory problems or Alzheimer's disease earlier than those without epilepsy, according to a new study. "Careful identification and treatment of epilepsy in such patients may improve their clinical course," concluded Dr. Keith Vossel, of the Gladstone Institute of Neurological Disease in San Francisco, and colleagues. The researchers evaluated data on 54 patients and found that those with mild memory problems and epilepsy showed signs of mental decline nearly seven years earlier than those with mild memory problems who did not have epilepsy -- average age 64 years versus 71 years. In addition, Alzheimer's patients with epilepsy showed signs of mental decline about five years earlier than those with Alzheimer's who did not have epilepsy -- average age about 65 years versus 70 years, according to the findings published online July 8 in the journal JAMA Neurology. Alzheimer's increases a patient's risk of seizures, and patients with Alzheimer's and seizure disorders have greater mental impairment, more rapid progression of symptoms and show more severe loss of neurons at autopsy than those without seizures, the researchers noted in a journal news release. "Epileptic activity associated with Alzheimer's … Continue reading →

PARK CITY, UT--(Marketwired - Jul 16, 2013) - AurimMed Pharma, Inc., a biopharmaceutical company with an innovative approach to R&D and a unique Central Nervous System compound, has been named the first recipient of an award for the groundbreaking product for people with epilepsy from the Epilepsy Foundation. The Epilepsy Innovation Seal of Excellence was awarded by the Epilepsy Foundation of America in recognition of AurimMed's innovative principal lead drug candidate designated AMP-X-0079. (http://www.epilepsy.com/etp/seal_of_excellence) "AurimMed has the highest respect for the Epilepsy Foundation and its leadership. We are pleased that they recognize our proprietary Privileged Structure Platform and our work towards the development of AMP-X-0079 for the treatment of epilepsy. This Award is an important and significant milestone in the evolution of AurimMed Pharma and the development of AMP-X-0079," said Amir Pesyan, Chairman and CEO of AurimMed. "The AMP-X-0079 program has all the characteristics that we seek for the Epilepsy Innovation Seal of Excellence award," notes Roger J. Porter, MD, Chief Scientific Officer of the Epilepsy Foundation. "This potential drug has very impressive data from the NIH-NINDS screening program and has been created using a proven platform for success in other disease states." Philip M. Gattone, President and CEO of … Continue reading →

Autism on the rise: How animals are helping GLENVILLE -- The Saratoga Therapeutic Equestrian Program (STEP) is a charitable, not-for-profit organization.The organization has been around since 1986 and ... By: CBS6Albany … Continue reading →

Video Military Families With Autism Concerned About Tricare Changes New TRICARE rules set to take affect on July 25 would prevent military children with autism from getting much-needed treatment, according to an autism advocacy group. According to the Autism Speaks, the TRICARE changes require: -Standardized testing every 6 months in order to continue receiving care -Evidence of "measurable progress" as indicated by standardized testing results to receive continued therapy -Waivers to continue care beyond two years of treatment and after age 16 -New discharge criteria for failure to make progress, sustainable gains, or a parent's inability to participate in the treatment Critics of the TRICARE requirements say autistic children who don't show progress within six months would be denied care. U.S. Senators Kirsten Gillibrand and Patty Murray have taken up the cause, sending a letter to Assistant Secretary of Defense for Health Affairs and Director of TRICARE Management Activity, Dr. Jonathan Woodson. That letter reads, in part: "Given the impact family health care plays on military readiness, it is essential military families have assurances of continued health care. Policies inconsistent with good clinical practice only serve to limit, restrict, delay, and deny care. The apparent lack of understanding of the … Continue reading →

Posted on: 7:19 pm, July 16, 2013, by Jessica Larche, updated on: 09:40pm, July 16, 2013 Beginning July 25, 2013, Tricare will make it a lot tougher for military families with autistic children to qualify for Applied Behavior Analysis therapy, or ABA. Families and providers have planned a demonstration this Sunday, July 21, 2013 at 1535 Amberly Forest Road in Virginia Beach. Click here for more information. Below is a statement from Tricare NewsChannel 3 has been waiting days to receive: The Department of Defense is greatly expanding applied behavior analysis (ABA) services with introduction of the ABA Pilot for non-active duty family members starting July 25. These changes are being made to provide non active duty family members, including retirees, with access to additional areas of ABA reinforcement. There is no change in the services available to active duty family members. Active Duty Family members Active duty family members (ADFMs) and Non Active Duty Family Members, such as retirees, continue to be eligible to receive medical and behavioral health services such treatment by a physician, psychological services and testing; occupational and physical therapy and other medical treatments under the TRICARE basic medical program. In addition, Active Duty Family Members … Continue reading →